Aurinia Pharmaceuticals Inc
NASDAQ:AUPH

Watchlist Manager
Aurinia Pharmaceuticals Inc Logo
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Watchlist
Price: 8.14 USD -1.45%
Market Cap: 1.2B USD
Have any thoughts about
Aurinia Pharmaceuticals Inc?
Write Note

Aurinia Pharmaceuticals Inc
Cash & Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Aurinia Pharmaceuticals Inc
Cash & Cash Equivalents Peer Comparison

Comparables:
B
DRUG
TH
RPTX
COV
EDT

Competitive Cash & Cash Equivalents Analysis
Latest Figures & CAGR of Competitors

Company Cash & Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
Cash & Cash Equivalents
$36.6m
CAGR 3-Years
-14%
CAGR 5-Years
-23%
CAGR 10-Years
4%
B
Bright Minds Biosciences Inc
CNSX:DRUG
Cash & Cash Equivalents
CA$19.8m
CAGR 3-Years
191%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Theratechnologies Inc
TSX:TH
Cash & Cash Equivalents
$38.9m
CAGR 3-Years
-9%
CAGR 5-Years
5%
CAGR 10-Years
33%
Repare Therapeutics Inc
NASDAQ:RPTX
Cash & Cash Equivalents
$111.3m
CAGR 3-Years
-30%
CAGR 5-Years
60%
CAGR 10-Years
N/A
Covalon Technologies Ltd
XTSX:COV
Cash & Cash Equivalents
CA$9.4m
CAGR 3-Years
39%
CAGR 5-Years
52%
CAGR 10-Years
9%
Spectral Medical Inc
TSX:EDT
Cash & Cash Equivalents
CA$5.8m
CAGR 3-Years
-19%
CAGR 5-Years
14%
CAGR 10-Years
-7%

See Also

What is Aurinia Pharmaceuticals Inc's Cash & Cash Equivalents?
Cash & Cash Equivalents
36.6m USD

Based on the financial report for Sep 30, 2024, Aurinia Pharmaceuticals Inc's Cash & Cash Equivalents amounts to 36.6m USD.

What is Aurinia Pharmaceuticals Inc's Cash & Cash Equivalents growth rate?
Cash & Cash Equivalents CAGR 10Y
4%

Over the last year, the Cash & Cash Equivalents growth was -20%. The average annual Cash & Cash Equivalents growth rates for Aurinia Pharmaceuticals Inc have been -14% over the past three years , -23% over the past five years , and 4% over the past ten years .

Back to Top